Cwm Taf Morgannwg University Health Board (CTMUHB) (Welsh: Bwrdd lechyd Prifysgol Cwm Taf Morgannwg) is the local health board of NHS Wales for Merthyr Tydfil, Rhondda Cynon Taf, and Bridgend in the south of Wales. It was renamed from Cwm Taf University Health Board on 1 April 2019 following the transfer of Bridgend County Borough from the former Abertawe Bro Morgannwg University Health Board (now Swansea Bay University Health Board).It was established in 2009 as the legal successor organisation to Cwm Taf NHS Trust (Welsh: Ymddiriedolaeth GIG Cwm Taf). The Trust was formed on 1 April 2008, following the merger of the North Glamorgan and Pontypridd & Rhondda NHS Trusts. Cwm Taf Morgannwg University Health Board is the operational name of Cwm Taf Morgannwg Local Health Board.Cwm Taf Morgannwg University Health Board provides healthcare services mainly for the population of Merthyr Tydfil County Borough, Rhondda Cynon Taf County Borough and (from 1 April 2019) Bridgend County Borough. Cwm Taf Morgannwg NHS Trust's headquarters are in Ynysmeurig House, Navigation Park, Abercynon, Wales.
Renin–angiotensin–aldosterone system inhibitor (RAASi) therapies are a cornerstone of guideline-directed medical therapy in the management of cardiorenal disease, including chronic kidney disease and heart failure. Management guidelines state that these therapies should be prescribed at the maximum licensed or tolerated dose in order to prevent disease progression and adverse events. However, both cardiorenal disease and RAASi therapies increase the risk of hyperkalaemia. When hyperkalaemia occurs, clinicians often down-titrate or discontinue these important RAASi therapies, leaving patients at risk of adverse cardiorenal outcomes. Eleven cardiorenal experts considered how hyperkalaemia can act as a barrier to optimised RAASi therapy in patients with cardiorenal disease and how these issues could be mitigated. Four key areas of suboptimal and variable clinical practice were identified: optimisation of RAASi therapy; definition and management of acute hyperkalaemia; secondary to primary care communications; and patient education. In this podcast article, two of the experts discuss the clinical challenges and principles of optimal care for each of the four areas identified. The experts agreed that hyperkalaemia should be considered a predictable and manageable condition, requiring a pre-emptive and long-term approach. When hyperkalaemia occurs, down-titrating or discontinuing RAASi therapy should be a last resort, after all other management approaches have been employed. Healthcare professionals in secondary and primary care must communicate and collaborate to ensure effective, consistent management of patients with cardiorenal disease. Finally, patients should be educated to understand their cardiorenal disease and its management and the importance of optimal RAASi therapy.
Using visualisation to conceptualise a chronic condition can encourage accurate illness beliefs and support treatment adherence. Hi-BP is a digital visual intervention to support adherence to antihypertensive medication, co-produced with patients. The aim of this study was to investigate the feasibility and acceptability of Hi-BP and explore the preliminary direction of effects on illness and treatment beliefs, medication adherence and blood pressure (BP). A two-phased mixed-methods non-randomised feasibility study was conducted from April 2021 to March 2022 in eight community pharmacies across one Health Board in South-East Wales, UK. Hi-BP was delivered as a single researcher-led consultation to 69 patients in Phase 1 and by pharmacists to three patients in Phase 2. Feasibility was determined using predefined criteria, with acceptability explored qualitatively using semi-structured interviews. Quantitative outcome measures (illness perceptions, medication beliefs, medication-adherence, prescription dispensing and collection data, BP) were recorded at baseline and immediately post-intervention.Follow-up outcome measures were collected at two-weeks (medication-adherence) and three-months (all baseline measures). Hi-BP met feasibility criteria for pharmacist recruitment in both phases, and patient recruitment in Phase 1, but not Phase 2. Hi-BP was acceptable to the sub-sample of 15 patient participants interviewed in Phase 1; insufficient data were available to determine patient acceptability at Phase 2. Hi-BP was acceptable to pharmacists in Phase 1 and partially acceptable at Phase 2, due to competing demands on time for intervention delivery. All outcome measures were considered feasible for use, though a ceiling effect was noted for medication adherence. A potentially positive directional effect was found for illness perceptions (X2(2)=10.83,n=54,p=0.004), medication beliefs (BMQ-Necessity (X2(2)=11.71,n=54,p=0.003) and BP (Systolic BP Z=-3.91,n=51,p=<0.001) but not for medication adherence (MARS-5 X2(2)= 2.4,n=45,p=0.299). In the Community Pharmacy setting, Hi-BP was well-accepted and has the potential for significant reductions in BP; however, further research is needed to explore pharmacist capacity to support implementation.
Disposable post-consumer diaper (nappy) waste represents a growing and compositionally complex waste stream containing recoverable materials with considerable potential for civil engineering applications. This systematic review critically evaluates the utilisation of post-consumer disposable diaper waste and its recovered constituents across civil engineering applications, linking laboratory-scale research with emerging industrial recycling and material-recovery pathways. The review demonstrates that engineering performance is strongly dependent on the intended application, processing method, replacement level and recovered material fraction. Direct incorporation of processed nappy waste provides a relatively simple waste-diversion route but is frequently associated with reductions in mechanical strength, increased porosity and variability arising from material heterogeneity. In contrast, selective recovery enables superabsorbent polymers, cellulose fibres and polyolefin fractions to be utilised according to their distinct moisture-regulating, reinforcing and material-modifying properties. Applications in concrete, mortar and plaster, masonry products, and soil and geotechnical engineering demonstrate differing levels of technical feasibility, performance benefits and limitations. Importantly, this review integrates evidence from civil engineering applications with existing and emerging industrial nappy-recycling technologies, highlighting opportunities for component-based resource recovery within a circular-economy framework. Key priorities for future research and implementation include standardisation and characterisation of recovered materials, assessment of long-term durability and field performance, development of scalable and hygienically robust recovery processes, and comprehensive life-cycle environmental and economic evaluation.
Coercive and controlling behaviour can have long-term consequences for victims and often precedes physical violence or homicide. Due to its subtle presentation and the normalisation of abusive behaviours, it frequently goes unrecognised. Healthcare settings provide an opportunity to identify abuse, enabling earlier intervention and potentially better long-term outcomes. This review sought to identify screening tools and interventions used by healthcare professionals to detect and support individuals experiencing domestic abuse, and to evaluate their relevance for recognising and responding to coercive control. JBI scoping review methodology was used. Any screening tool undertaken by a healthcare professional in an OECD country was included as well as any intervention that a survivor could be referred to; 149 studies met inclusion criteria. Relevance to Coercive control was refined through consultation with professionals and individuals with lived experience. Thirty-nine screening tools and seventy-one interventions were identified. Most tools (n = 35) focused on specific forms of violence and were mapped into thematic domains. Ninety-two studies described interventions, although detail varied. No tool or intervention was specifically designed to identify or respond to coercive control. Existing screening tools and interventions are largely violence-focused and are insufficient for identifying or responding to coercive control. Recognition and disclosure depend on professional knowledge, confidence, and supportive organisational systems rather than tools alone. The absence of responses specific to coercive control represents a significant gap in healthcare practice, underscoring the need for trauma-informed, relational, and system-level approaches that better reflect survivors’ lived experiences.